XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Sep. 30, 2023
Oct. 01, 2022
Cash Flows from Operating Activities:    
Net income $ 65,950 $ 53,074
Non-cash items:    
Depreciation and amortization 46,045 45,883
Share-based compensation expense 13,695 11,034
Impairment of assets 10,419 94
Amortization of deferred financing costs 1,610 313
Inventory reserve adjustment 2,559 (1,529)
Other non-cash operating activities (1,836) (2,072)
Change in operating assets and liabilities:    
Change in accounts receivable 2,857 (17,043)
Change in inventories (30,654) 35,990
Change in prepaid income taxes (906) 2,145
Change in other assets and other liabilities (10,291) (7,724)
Change in accounts payable and accrued expenses 18,762 8,867
Net cash provided by operating activities 118,210 129,032
Cash Flows from Investing Activities:    
Capital expenditures (34,317) (81,424)
Acquisition 0 (2,850)
Proceeds from divestiture 0 850
Proceeds from sale of property, plant and equipment 921 7,537
Other investments (7,000) (13,395)
Net cash used in investing activities (40,396) (89,282)
Cash Flows from Financing Activities:    
Term loan borrowings 0 280,000
Term loan redemption 0 (280,000)
Proceeds from revolving facility 0 50,000
Debt issuance costs 0 (1,118)
Share repurchases 0 (75,000)
Repayment of term loan borrowings (5,250) (6,125)
Contingent consideration payments (849) (21,593)
Proceeds from employee stock purchase plan 2,871 2,459
Proceeds from exercise of stock options 1,319 2,319
Cash used to net share settle employee equity awards (5,842) 0
Other financing activities (19) (23)
Net cash used in financing activities (7,770) (49,081)
Effect of exchange rates on cash and cash equivalents (3,505) (8,965)
Net Change in Cash and Cash Equivalents 66,539 (18,296)
Cash and Cash Equivalents at Beginning of Period 284,466 259,496
Cash and Cash Equivalents at End of Period 351,005 241,200
Supplemental Disclosures of Cash Flow Information:    
Transfers from inventory to fixed assets for placement of Haemonetics equipment $ 17,523 $ 66,452